Condition
Merosin Deficient CMD (Full or Partial)
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07125040Recruiting
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
NCT06924125Recruiting
Spanish Natural History Study for LAMA2 Muscular Dystrophy
NCT01403402Recruiting
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Showing all 3 trials